Pancreatic Cancer Research

ResearcherTabriz University of Medical SciencesActive in the last 2 years

Behzad Baradaran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-8642-6795; OpenAlex author ID A5008839777. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 6 papers · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 15

  1. Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.clim.2026.110665↗
  2. Exploring the potential of gemcitabine-metal-organic frameworks in combating pancreatic cancer under ketogenic conditions. Co-author DOI 10.1186/s12885-024-13397-x↗
  3. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel. Last author DOI 10.1007/s12033-023-00872-2↗
  4. Unraveling dedifferentiation and metastasis traces in pancreatic ductal adenocarcinoma ductal cells: Insights from single-cell RNA sequencing analysis of ITGB4… Last author DOI 10.1016/j.prp.2023.155012↗
  5. Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction. Last author DOI 10.1007/s12032-023-02163-x↗
  6. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line. Last author DOI 10.1002/tox.23103↗
  7. Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development. Last author DOI 10.1016/j.apsb.2020.12.011↗
  8. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejphar.2021.174006↗
  9. Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim? Last author DOI 10.1016/j.imlet.2021.02.009↗
  10. Simultaneous microRNA-612 restoration and 5-FU treatment inhibit the growth and migration of human PANC-1 pancreatic cancer cells. Last author DOI 10.17179/excli2020-2900↗
  11. Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment. Last author DOI 10.3390/biomedicines9040373↗
  12. Targeting immune checkpoints: Building better therapeutic puzzle in pancreatic cancer combination therapy. Last author DOI 10.1111/ecc.13268↗
  13. Enhanced Anticancer Potency of Hydroxytyrosol and Curcumin by PLGA-PAA Nano-Encapsulation on PANC-1 Pancreatic Cancer Cell Line Last author DOI 10.20944/preprints202011.0215.v1↗
  14. Enhanced Anticancer Potency of Hydroxytyrosol and Curcumin by PLGA-PAA Nano-Encapsulation on PANC-1 Pancreatic Cancer Cell Line Last author DOI 10.21203/rs.3.rs-108173/v1↗
  15. Dysregulation of key microRNAs in pancreatic cancer development. Co-author DOI 10.1016/j.biopha.2018.10.177↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Darya Javadrashid · 3 shared papers, 2021 · strength 0.42
  2. Ziba Lotfi · 3 shared papers, 2021 · strength 0.41
  3. Zahra Asadzadeh · 2 shared papers, 2021–2024 · strength 0.38
  4. Ahad Mokhtarzadeh · 2 shared papers, 2021–2024 · strength 0.37
  5. Afshin Derakhshani · 2 shared papers, 2021–2026 · strength 0.37
  6. Vito Racanelli · 2 shared papers, 2021–2026 · strength 0.37
  7. Nicola Silvestris · 2 shared papers, 2021–2026 · strength 0.37
  8. Mahdieh Farhoudi Sefidan Jadid · 3 shared papers, 2020–2021 · strength 0.33
  9. Alireza Isazadeh · 3 shared papers, 2020–2021 · strength 0.33
  10. Javad Behroozi · 2 shared papers, 2021–2023 · strength 0.32
  11. Masoumeh Tavakoli‐Yaraki · 1 shared paper, 2025 · strength 0.28
  12. Samira Nekoufar · 1 shared paper, 2025 · strength 0.28
  13. Riccardo Memeo · 1 shared paper, 2026 · strength 0.23
  14. Amalia Azzariti · 1 shared paper, 2026 · strength 0.23
  15. Oronzo Brunetti · 1 shared paper, 2026 · strength 0.23
  16. Mario Testini · 1 shared paper, 2026 · strength 0.23
  17. Letizia Porcelli · 1 shared paper, 2026 · strength 0.23
  18. Adib Miraki Feriz · 1 shared paper, 2026 · strength 0.23
  19. Negin Riazi Tabrizi · 1 shared paper, 2024 · strength 0.23
  20. Mohammad Heiat · 1 shared paper, 2023 · strength 0.20
  21. Monireh Khordadmehr · 1 shared paper, 2019 · strength 0.16
  22. Antonio Giovanni Solimando · 1 shared paper, 2021 · strength 0.14
  23. Seyed Hossein Kiaie · 1 shared paper, 2021 · strength 0.14
  24. Sina Abdkarimi · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.